Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Dec 20, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000135.pdf 0001883850-22-000135.xls
Dec 20, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000136.pdf 0001883850-22-000136.xls
Dec 20, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000134.pdf 0001883850-22-000134.xls
Dec 20, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000133.pdf 0001883850-22-000133.xls
Dec 20, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000137.pdf 0001883850-22-000137.xls
Dec 20, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000139.pdf 0001883850-22-000139.xls
Dec 13, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000117.pdf 0001883850-22-000117.xls
Dec 13, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000120.pdf 0001883850-22-000120.xls
Dec 13, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000119.pdf 0001883850-22-000119.xls
Dec 13, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000118.pdf 0001883850-22-000118.xls

Data provided by Kaleidoscope.

Investors & Media